Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 14Lung Neoplasms 8Prostatic Neoplasms 6Colorectal Neoplasms 6Neoplasms 5Pancreatic Neoplasms 3Ovarian Neoplasms 3Lymphoma 3Smoking Cessation 2Skin Carcinoma 2Pain 2Melanoma 2Malignant Solid Neoplasm 2Leukemia, Myeloid, Acute 2Hematopoietic and Lymphatic System Neoplasm 2Carcinoma, Non-Small-Cell Lung 2Anatomic Stage I Breast Cancer AJCC v8 2Advanced Malignant Solid Neoplasm 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Tobacco Smoking 1Testicular Neoplasms 1Spondylitis, Ankylosing 1Smoking 1Signs and Symptoms 1Sepsis 1Rectal Neoplasms 1Psoriasis 1

Interventions

Nivolumab 2pembrolizumab 1cabozantinib 1Standard of Care 1Specimen Handling 1Practice Guidelines as Topic 1Platinum Compounds 1Methods 1Ipilimumab 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colitis, Ulcerative × Methods × 90 days × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡